Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Vor Biopharma Inc Is A Clinical-Stage Biopharmaceutical Company Focused On Developing Novel Therapies For The Treatment Of Autoimmune Diseases. Its Program, Telitacicept, Is A Potential First- And Best-In-Class Dual Baff/April Inhibitor Designed To Suppress The Signaling Pathways That Drive The Maturation, Proliferation, And Survival Of Harmful B Cells, Including Self-Reactive B Cells, Thereby Reducing Autoantibody Production And Preventing Downstream Tissue Damage.